Market closed· · SEK · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Total return, dividends included.
Where the price sits against its 50- and 200-day moving averages.
Makkler Fair Value, financial health score, analyst view, peers and MakklerAI.
The Annual General Meeting of Swedish Orphan Biovitrum AB (publ) (Sobi®) on 6 May 2026 resolved on a directed issue of redeemable and convertible class C shares and to authorise the Board of Directors to resolve on the repurchase of all issued class C shares through an acquisition offer directed to all owners of class C shares in Sobi. The Board of Directors of Sobi has, as previously communicated, on 15 July 2026 resolved to, conditional upon subscription and payment from Svenska Handelsbanken
Svenska Handelsbanken AB (SVNLF) reports solid operating profit and strong asset quality, despite facing margin pressures and increased regulatory fees.
If you are wondering whether Svenska Handelsbanken is priced fairly or offering value right now, the stock's recent track record and current checks on value make it worth a closer look. The share price last closed at SEK134.55, with returns of 3.9% over the past 30 days, a decline of 0.8% over the last week, a decline of 1.0% year to date, and 20.1% over the past year, while the 3 year return is 115.2% and the 5 year return is 150.5%. Recent moves in the share price sit alongside ongoing...
Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.